Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study
Purpose Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing respiratory sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed to evaluate the influence of socio-economic status on respiratory sequelae after COVID-19 ARDS. Methods We carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled the Berlin ARDS criteria. For patients receiving high flow oxygen therapy, a flow ≥ 50 l/min and an $ FiO_{2} $ ≥ 50% were required for enrollment. Socio-economic deprivation was defined by an EPICES (Evaluation de la Précarité et des Inégalités de santé dans les Centres d’Examens de Santé - Evaluation of Deprivation and Inequalities in Health Examination Centres) score ≥ 30.17 and patients were included if they performed the 6-month evaluation. The primary outcome was respiratory sequelae 6 months after ICU discharge, defined by at least one of the following criteria: forced vital capacity < 80% of theoretical value, diffusing capacity of the lung for carbon monoxide < 80% of theoretical value, oxygen desaturation during a 6-min walk test and fibrotic-like findings on chest computed tomography. Results Among 401 analyzable patients, 160 (40%) were socio-economically deprived and 241 (60%) non-deprived; 319 (80%) patients had respiratory sequelae 6 months after ICU discharge (81% vs 78%, deprived vs non-deprived, respectively). No significant effect of socio-economic status was identified on lung sequelae (odds ratio (OR), 1.19 [95% confidence interval (CI), 0.72–1.97]), even after adjustment for age, sex, most invasive respiratory support, obesity, most severe P/F ratio (adjusted OR, 1.02 [95% CI 0.57–1.83]). Conclusions In COVID-19 ARDS survivors, socio-economic status had no significant influence on respiratory sequelae 6 months after ICU discharge..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
Intensive care medicine - 49(2023), 10 vom: 24. Aug., Seite 1168-1180 |
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
Anmerkungen: |
© The Author(s) 2023 |
---|
doi: |
10.1007/s00134-023-07180-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR053308654 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR053308654 | ||
003 | DE-627 | ||
005 | 20231006081121.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231006s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00134-023-07180-y |2 doi | |
035 | |a (DE-627)SPR053308654 | ||
035 | |a (SPR)s00134-023-07180-y-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Declercq, Pierre-Louis |e verfasserin |4 aut | |
245 | 1 | 0 | |a Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2023 | ||
520 | |a Purpose Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing respiratory sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed to evaluate the influence of socio-economic status on respiratory sequelae after COVID-19 ARDS. Methods We carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled the Berlin ARDS criteria. For patients receiving high flow oxygen therapy, a flow ≥ 50 l/min and an $ FiO_{2} $ ≥ 50% were required for enrollment. Socio-economic deprivation was defined by an EPICES (Evaluation de la Précarité et des Inégalités de santé dans les Centres d’Examens de Santé - Evaluation of Deprivation and Inequalities in Health Examination Centres) score ≥ 30.17 and patients were included if they performed the 6-month evaluation. The primary outcome was respiratory sequelae 6 months after ICU discharge, defined by at least one of the following criteria: forced vital capacity < 80% of theoretical value, diffusing capacity of the lung for carbon monoxide < 80% of theoretical value, oxygen desaturation during a 6-min walk test and fibrotic-like findings on chest computed tomography. Results Among 401 analyzable patients, 160 (40%) were socio-economically deprived and 241 (60%) non-deprived; 319 (80%) patients had respiratory sequelae 6 months after ICU discharge (81% vs 78%, deprived vs non-deprived, respectively). No significant effect of socio-economic status was identified on lung sequelae (odds ratio (OR), 1.19 [95% confidence interval (CI), 0.72–1.97]), even after adjustment for age, sex, most invasive respiratory support, obesity, most severe P/F ratio (adjusted OR, 1.02 [95% CI 0.57–1.83]). Conclusions In COVID-19 ARDS survivors, socio-economic status had no significant influence on respiratory sequelae 6 months after ICU discharge. | ||
650 | 4 | |a ARDS |7 (dpeaa)DE-He213 | |
650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
650 | 4 | |a Socio-economic |7 (dpeaa)DE-He213 | |
650 | 4 | |a Deprivation |7 (dpeaa)DE-He213 | |
650 | 4 | |a Respiratory sequelae |7 (dpeaa)DE-He213 | |
700 | 1 | |a Fournel, Isabelle |4 aut | |
700 | 1 | |a Demeyere, Matthieu |4 aut | |
700 | 1 | |a Berraies, Anissa |4 aut | |
700 | 1 | |a Ksiazek, Eléa |4 aut | |
700 | 1 | |a Nyunga, Martine |4 aut | |
700 | 1 | |a Daubin, Cédric |4 aut | |
700 | 1 | |a Ampere, Alexandre |4 aut | |
700 | 1 | |a Sauneuf, Bertrand |4 aut | |
700 | 1 | |a Badie, Julio |4 aut | |
700 | 1 | |a Delbove, Agathe |4 aut | |
700 | 1 | |a Nseir, Saad |4 aut | |
700 | 1 | |a Artaud-Macari, Elise |4 aut | |
700 | 1 | |a Bironneau, Vanessa |4 aut | |
700 | 1 | |a Ramakers, Michel |4 aut | |
700 | 1 | |a Maizel, Julien |4 aut | |
700 | 1 | |a Miailhe, Arnaud-Felix |4 aut | |
700 | 1 | |a Lacombe, Béatrice |4 aut | |
700 | 1 | |a Delberghe, Nicolas |4 aut | |
700 | 1 | |a Oulehri, Walid |4 aut | |
700 | 1 | |a Georges, Hugues |4 aut | |
700 | 1 | |a Tchenio, Xavier |4 aut | |
700 | 1 | |a Clarot, Caroline |4 aut | |
700 | 1 | |a Redureau, Elise |4 aut | |
700 | 1 | |a Bourdin, Gaël |4 aut | |
700 | 1 | |a Federici, Laura |4 aut | |
700 | 1 | |a Adda, Mélanie |4 aut | |
700 | 1 | |a Schnell, David |4 aut | |
700 | 1 | |a Bousta, Mehdi |4 aut | |
700 | 1 | |a Salmon-Gandonnière, Charlotte |4 aut | |
700 | 1 | |a Vanderlinden, Thierry |4 aut | |
700 | 1 | |a Plantefeve, Gaëtan |4 aut | |
700 | 1 | |a Delacour, David |4 aut | |
700 | 1 | |a Delpierre, Cyrille |4 aut | |
700 | 1 | |a Le Bouar, Gurvan |4 aut | |
700 | 1 | |a Sedillot, Nicholas |4 aut | |
700 | 1 | |a Beduneau, Gaëtan |4 aut | |
700 | 1 | |a Rivière, Antoine |4 aut | |
700 | 1 | |a Meunier-Beillard, Nicolas |4 aut | |
700 | 1 | |a Gélinotte, Stéphanie |4 aut | |
700 | 1 | |a Rigaud, Jean-Philippe |4 aut | |
700 | 1 | |a Labruyère, Marie |4 aut | |
700 | 1 | |a Georges, Marjolaine |4 aut | |
700 | 1 | |a Binquet, Christine |4 aut | |
700 | 1 | |a Quenot, Jean-Pierre |0 (orcid)0000-0003-2351-682X |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d Berlin : Springer, 1975 |g 49(2023), 10 vom: 24. Aug., Seite 1168-1180 |w (DE-627)SPR001167375 |w (DE-600)1459201-0 |x 1432-1238 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2023 |g number:10 |g day:24 |g month:08 |g pages:1168-1180 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00134-023-07180-y |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 49 |j 2023 |e 10 |b 24 |c 08 |h 1168-1180 |